Skip to main content
. 2017 Jul 26;8(35):59748–59756. doi: 10.18632/oncotarget.19574

Figure 2. The Oxford classification (MEST) pathologic lesions response to steroid therapy in the patients with IgA nephropathy.

Figure 2